Study on the clinical characteristics, persistent infection capability and viral load of human papillomavirus type 26 single infection

被引:1
|
作者
Chen, Zuyi [1 ,2 ]
Li, Xiaoyang [3 ]
Tian, Di [1 ,2 ]
Liu, Jingchi [1 ,2 ]
Bai, Xia [1 ,2 ]
Feng, Tingting [1 ,2 ]
Chen, Shiqi [1 ,2 ]
Chen, Lin [4 ]
Li, Qiongyao [5 ]
机构
[1] Zunyi Med Univ, Affiliated Hosp, Dept Lab Med, Zunyi, Peoples R China
[2] Zunyi Med Univ, Sch Lab Med, Zunyi, Peoples R China
[3] Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Sichuan Clin Res Ctr Canc, Sichuan Canc Ctr,Affiliated Canc Hosp,Gen Off, Chengdu, Peoples R China
[4] Chongqing Med Univ, Nanchuan Hosp, Chongqing, Peoples R China
[5] Zunyi Med Univ, Affiliated Hosp, Dept Informat, Zunyi, Peoples R China
基金
中国国家自然科学基金;
关键词
Human papillomavirus type 26; Cervical intraepithelial neoplasia; Persistent infection; Pathogenicity; Viral load; CANCER; WOMEN; RISK;
D O I
10.1186/s12985-024-02582-w
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background Human papillomavirus (HPV) infection is the main cause of cervical cancer. Different types of HPV have varying carcinogenic capabilities, and viral load is one of the key indicators of pathogenicity. Currently, there is a lack of clinical data on HPV26. This study analyzed the clinical characteristics of patients with HPV26 single infection. Methods Exfoliated cervical cells were collected for HPV genotyping from women who attended gynecological outpatient clinics or physical examinations. The clinical characteristics of HPV26 single infections in both cross-sectional and follow-up studies were examined, and the association of viral load with HPV26 persistent infection and pathogenicity was investigated. Results The HPV26 positive rate among women visiting hospitals for gynecological medical consultation or physical examination was approximately 0.09% (379/435,072). Among the HPV types tested, the detection rate of HPV26 was 0.37% (379/103,608). In the cross-sectional histopathological study of 101 patients with HPV26 single infection, 62.37% (63/101) presented lesion-free. The numbers of patients with cervical intraepithelial neoplasia (CIN) 1, CIN2, and CIN3 were 25, eight, and five, respectively. Cervical cancer was not detected in any patient. 71 patients attended follow-up examinations as well as HPV26 retesting up to two years, during which, 28.57% (6/21) of CIN1 patients have developed into high-grade lesions, and 9.61% (5/52) of lesion-free patients have progressed to CIN stage. The viral load in the CIN group was significantly higher than that in the lesion-free group (p = 0.012). Similarly, the viral load in the persistent infection group was significantly higher than that in the viral-clearance group (p < 0.001). Conclusions The pathogenicity of single HPV26 infections is moderate among high-risk types, warranting the inclusion of HPV26 in expanded screening for HPV. High viral load is an important factor in the persistent infection and pathogenicity of HPV26. Viral load is expected to serve as a screening risk factor for persistent infection and disease progression associated with HPV26.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Clinical performance of Anyplex II HPV28 by human papillomavirus type and viral load in a referral population
    Baasland, Ingrid
    Romundstad, Pal R.
    Eide, Maj Liv
    Jonassen, Christine M.
    PLOS ONE, 2019, 14 (01):
  • [22] The Reservoir of Persistent Human Papillomavirus Infection; Strategies for Elimination Using Anti-Viral Therapies
    Zheng, Ke
    Egawa, Nagayasu
    Shiraz, Aslam
    Katakuse, Mayako
    Okamura, Maki
    Griffin, Heather M.
    Doorbar, John
    VIRUSES-BASEL, 2022, 14 (02):
  • [23] Alcohol consumption and persistent infection of high-risk human papillomavirus
    Oh, H. Y.
    Kim, M. K.
    Seo, S.
    Lee, D. O.
    Chung, Y. K.
    Lim, M. C.
    Kim, J.
    Lee, C. W.
    Park, S.
    EPIDEMIOLOGY AND INFECTION, 2015, 143 (07) : 1442 - 1450
  • [24] Biomarkers of oxidant load and type-specific clearance of prevalent oncogenic human papillomavirus infection: Markers of immune response?
    Siegel, Erin M.
    Patel, Nitin
    Lu, Beibei
    Lee, Ji-Hyun
    Nyitray, Alan G.
    Craft, Neal E.
    Frenkel, Krystyna
    Villa, Luisa L.
    Franco, Eduardo L.
    Giuliano, Anna R.
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (01) : 219 - 228
  • [25] Characteristics of bacterial vaginosis infection in cervical lesions with high risk human papillomavirus infection
    Lu, Huan
    Jiang, Peng-Cheng
    Zhang, Xiao-Dan
    Hou, Wen-Jing
    Wei, Zhen-Hong
    Lu, Jia-Qi
    Zhang, Hao
    Xu, Guang-Xu
    Chen, Yuan-Ping
    Ren, Yuan
    Wang, Li
    Zhang, Rong
    Han, Ying
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (11): : 21080 - 21088
  • [26] Persistent Human Papillomavirus Infection in the Etiology of Cervical Carcinoma: The Role of Immunological, Genetic, Viral and Cellular Factors
    Zivadinovic, Radomir
    Petric, Aleksandra
    Lilic, Goran
    Lilic, Vekoslav
    Djordjevic, Biljana
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2014, 142 (5-6) : 378 - 383
  • [27] Types and viral load of human papillomavirus, and vaginal microbiota in vaginal intraepithelial neoplasia: a cross-sectional study
    Zhou, Fang-Yue
    Zhou, Qi
    Zhu, Zhong-Yi
    Hua, Ke-Qin
    Chen, Li-Mei
    Ding, Jing-Xin
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (21)
  • [28] Human papillomavirus type 16 viral load is decreased following a therapeutic vaccination
    Coleman, Hannah N.
    Greenfield, William W.
    Stratton, Shawna L.
    Vaughn, Rita
    Kieber, Alexander
    Moerman-Herzog, Andrea M.
    Spencer, Horace J.
    Hitt, Wilbur. C.
    Quick, Charles Matthew
    Hutchins, Laura F.
    Mackintosh, Samuel G.
    Edmondson, Ricky D.
    Erickson, Stephen W.
    Nakagawa, Mayumi
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2016, 65 (05) : 563 - 573
  • [29] Human papillomavirus type 16 viral load is decreased following a therapeutic vaccination
    Hannah N. Coleman
    William W. Greenfield
    Shawna L. Stratton
    Rita Vaughn
    Alexander Kieber
    Andrea M. Moerman-Herzog
    Horace J. Spencer
    Wilbur. C. Hitt
    Charles Matthew Quick
    Laura F. Hutchins
    Samuel G. Mackintosh
    Ricky D. Edmondson
    Stephen W. Erickson
    Mayumi Nakagawa
    Cancer Immunology, Immunotherapy, 2016, 65 : 563 - 573
  • [30] Cervicovaginal Gardnerella sialidase-encoding gene in persistent human papillomavirus infection
    Novak, Juliano
    Belleti, Rafael
    Pinto, Gabriel Vitor da Silva
    Bolpetti, Aline do Nascimento
    da Silva, Marcia Guimaraes
    Marconi, Camila
    SCIENTIFIC REPORTS, 2023, 13 (01)